Evidence map›Paper›PMID 35893556›Full record

ReviewMicroorganisms2022

Takumi Tanaka, Yuki Terauchi, Akira Yoshimi, Keietsu Abe

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Establishment of CRISPR/Cas9 Genome Editing inJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Hydrophobins inFrontiers in fungal biology · 2025
    Article
  11. Review
  12. Article
  13. Comparative genomics of the extremophileFrontiers in fungal biology · 2024
    Article
  14. Article
  15. Morphology ofLife (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Takumi TanakaLaboratory of Breeding Engineering for Koji Mold, Department of Biotechnology, Graduate School of Engineering, Osaka University, Suita 565-0871, Japan.
Yuki TerauchiTerrestrial Microbiology and Systematics, Graduate School of Global Environmental Studies, Kyoto University, Kyoto 606-8502, Japan.
Akira YoshimiLaboratory of Environmental Interface Technology of Filamentous Fungi, Kyoto University, Kyoto 606-8502, Japan.ORCID 0000-0003-4331-2744
Keietsu AbeNew Industry Creation Hatchery Center, Tohoku University, Sendai 980-8579, Japan.ORCID 0000-0001-5344-3794
Tohoku University · JPKyoto University · JPThe University of Osaka · JP

Funding

Institute for Fermentation, Osaka, Japan K-2019-002Institute for Fermentation, Osaka, Japan K-2021-008Japan Society for the Promotion of Science 17H03787Japan Society for the Promotion of Science Fellows 18J11900
6 · The paper itself

Abstract

Hydrophobins are small amphipathic proteins conserved in filamentous fungi. In this review, the properties and functions of

Indexed as

Aspergillusbiopolymer degradationhydrophobinself-assemblysmall secreted protein

Identifiers

PMID35893556
PMCPMC9394342
OpenAlexW4287835845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.